Lianbo Yu

plasma is a supervised multiomics method that integrates features into biologically relevant components to predict patient outcomes, outperforming unsupervised and single-omics models.

This study shows HTLV-1 infected T cells release small extracellular vesicles that promote bone loss by stimulating osteoclasts, independent of RANKL expression.

RIGATonI identifies genomic alterations in tumors affecting lymphocyte infiltration using machine learning and integrates immune phenotype and function predictions.